A detailed history of Charles Schwab Investment Management Inc transactions in 23and Me Holding Co. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 267,405 shares of ME stock, worth $858,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
267,405
Previous 1,788,733 85.05%
Holding current value
$858,370
Previous $697,000 86.66%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.29 - $0.51 $441,185 - $775,877
-1,521,328 Reduced 85.05%
267,405 $93,000
Q2 2024

Aug 12, 2024

SELL
$0.36 - $0.61 $147,509 - $249,946
-409,748 Reduced 18.64%
1,788,733 $697,000
Q1 2024

May 08, 2024

SELL
$0.4 - $0.91 $94,752 - $215,562
-236,882 Reduced 9.73%
2,198,481 $1.17 Million
Q4 2023

Feb 06, 2024

BUY
$0.71 - $0.97 $155,169 - $211,992
218,549 Added 9.86%
2,435,363 $2.22 Million
Q3 2023

Nov 08, 2023

BUY
$0.96 - $2.01 $106,165 - $222,283
110,589 Added 5.25%
2,216,814 $2.17 Million
Q2 2023

Aug 09, 2023

BUY
$1.59 - $2.29 $33,644 - $48,456
21,160 Added 1.01%
2,106,225 $3.69 Million
Q1 2023

May 11, 2023

BUY
$2.05 - $2.87 $22,476 - $31,466
10,964 Added 0.53%
2,085,065 $4.75 Million
Q4 2022

Feb 13, 2023

BUY
$2.06 - $3.47 $385,533 - $649,417
187,152 Added 9.92%
2,074,101 $4.48 Million
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $3.69 Million - $7.26 Million
1,418,545 Added 302.85%
1,886,949 $5.4 Million
Q2 2022

Aug 15, 2022

BUY
$2.19 - $3.98 $827,187 - $1.5 Million
377,711 Added 416.47%
468,404 $1.16 Million
Q1 2022

May 13, 2022

BUY
$3.28 - $7.12 $188,190 - $408,510
57,375 Added 172.2%
90,693 $348,000
Q3 2021

Nov 16, 2021

BUY
$7.29 - $11.0 $242,888 - $366,498
33,318 New
33,318 $302,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $834M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.